本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

12.35
+0.85007.39%
盘后12.590.2400+1.94%19:51 EST
成交量:14.41万
成交额:175.00万
市值:4.18亿
市盈率:-11.70
高:12.50
开:11.50
低:10.99
收:11.50
52周最高:17.15
52周最低:9.70
股本:3,386.22万
流通股本:2,085.08万
量比:0.52
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-1.0556
每股收益(LYR):-1.0472
净资产收益率:-53.01%
总资产收益率:-34.72%
市净率:4.47
市盈率(LYR):-11.79

数据加载中...

2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K/A [Amend] - Current report
2022/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/21

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/29

重要事件披露

8-K - Current report
2021/04/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/28

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/27

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/24

重要事件披露

8-K - Current report